Amro Stino, MD

Dr. Stino has expertise in the treatment of neuromuscular disorders, with special clinical and research interest in the care of patients with acquired peripheral neuropathy. As director of the Michigan Medicine Peripheral Neuropathy Clinic, he provides multi-disciplinary care for patients. Additionally, Dr. Stino serves as a site principal investigator on multi-center studies in the areas of metabolic and autoimmune neuropathy. He is presently conducting an investigator initiated phase 1b trial on the novel use of Lenalidomide in anti-myelin-associated glycoprotein neuropathy.